Samabriva Biotechnology is a company that is creating a new method for producing biopharmaceuticals, chemicals, and biotech products using plants. Samabriva’s flexible platform combines the benefits of plant-based systems and traditional biomanufacturing techniques. By developing and cultivating high-yield plant clones in large-scale bioreactors it is possible to produce large quantities of high-value products more efficiently than traditional manufacturing methods.
| Website | https://samabriva.com/ |
| Employees | 11 (9 on RocketReach) |
| Founded | 2011 |
| Address | 72, Rue des Jacobins, Amiens, Hauts-de-France 80000, FR |
| Phone | +33 3 22 09 28 30 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Plant Based Pharmaceuticals, Biopharmaceutical Manufacturing, Plant Biotechnology, Plant Based Chemicals, Sustainable Biomanufacturing, Plant Cell Culture, Renewable Biomaterials, Biotechnology Platform, Bioprocessing, Agricultural Biotechnology |
| Competitors | athenahealth, eClinicalWorks, Zocdoc, NextGen Healthcare, CareCloud, CureMD, EPILEPSY & BEHAVIOR NEUROLOGICAL SERVICES LLC, Practice Fusion, Maxwell Health, HealthFusion Inc. +32 more (view full list) |
Looking for a particular SAMABRIVA employee's phone or email?
Marina Guillet is the Founder and Chief Executive Officer of SAMABRIVA.
9 people are employed at SAMABRIVA.
SAMABRIVA is based in Amiens, Hauts-de-France.